Table of Contents
Hepatitis is the inflammation of the liver, or more specifically, inflammation of the liver cells. There are different types of hepatitis, which may occur due to multiple reasons, ranging from consumption of contaminated food to certain sexual practices to alcohol overdose. Here, however, we will study a particular form of hepatitis, known as alcoholic hepatitis, in depth.
Alcoholic liver disease presents as three forms: (1) fatty liver, (2) alcoholic hepatitis and (3) cirrhosis.
Alcoholic hepatitis is the inflammation of the liver cells due to excess alcohol consumption over an extended period of time. Between 10% and 20% of individuals with alcoholism develop alcoholic hepatitis. This disease is still curable if detected in the early stages. However, if alcohol consumption is not tapered off, and the disease is not treated properly, it may worsen. Alcoholic hepatitis left untreated can even lead to additional health issues, such as cirrhosis or complete liver failure. Alcoholic hepatitis is usually accompanied by fatty liver disease, which is another disease that may be caused by excess intake of alcohol.
Fatty liver disease occurs when there is an abnormal accumulation of fat in the liver cells. Although it is often studied in relation to alcohol consumption, it actually occurs in two forms: alcoholic fatty liver disease and non-alcoholic fatty liver disease (NAFLD). Non-alcoholic steatohepatitis (NASH) is a type of NAFLD. Fatty liver is seen in > 90% of daily/binge drinkers.
While the cause of alcoholic fatty liver disease is clear, non-alcoholic fatty liver disease occurs due to many reasons other than alcohol consumption. These reasons include problems such as diabetes, high blood pressure, and a high level of blood lipids (e.g., in those with obesity). This type of fatty liver disease also eventually results in cirrhosis if not treated properly.
Cirrhosis, which is the end result of both alcoholic hepatitis and non-alcoholic fatty liver disease, is a condition where the liver fails to function properly due to long-term damage. This damage is usually caused by either alcohol or the risk factors for non-alcoholic fatty liver disease. This condition can lead to many complications and even more serious diseases, such as liver cancer.
- Alcohol: The major and most obvious risk factors for alcoholic hepatitis are the quantity of alcohol one consumes and the duration of intake. Though the exact amount which puts someone at risk is not known, it is roughly calculated to be about seven glasses of alcohol every single day for a period of at least 20 years.
- Gender: Apart from alcohol consumption, gender is also a risk factor because the way alcohol is processed in the body also plays an important role. This is why women tend to be at a greater risk of developing alcoholic hepatitis than men. The threshold for developing alcoholic liver disease in men is >14 drinks per week, whereas it is >7 drinks per week in women.
- Obesity: High levels of alcohol, accompanied by excess body weight, make someone more vulnerable not only to alcoholic hepatitis but also to fatty liver disease, which may progress to cirrhosis in the long run. High cholesterol levels also put patients at greater risk of developing non-alcoholic fatty liver disease.
- Genetic factor: Many studies indicate that there is a genetic component for alcohol-induced liver diseases.
- Environmental factors: Although it is hard to separate the genetic factors from the environmental ones, factors such as race and ethnicity also play a part. For example, African-Americans and Hispanics seem to be at greater risk for alcoholic hepatitis.
- Existing diseases: Pre-existing diseases, such as chronic infection with hepatitis C virus, metabolic syndrome, type 2 diabetes, hypothyroidism, or underactive pituitary gland, can increase the risk of developing NAFLD.
The damaged hepatocytes undergo abnormal repair, which leads to fibrosis. Fibrosis is the scarring and hardening of the liver and its cells. Extensive fibrosis disrupts the structure of the liver, causing the liver to shrink.
Non-alcoholic fatty liver disease
NAFLD results when the uptake of lipids by the liver overwhelms the mechanisms for triglyceride disposal, leading to the accumulation of fat within hepatocytes. This increased delivery of fatty acids to the liver causes the liver to swell up and malfunction. Insulin resistance is created, which leads to alcoholic hepatitis. NAFLD is also said to be the leading cause of cryptogenic cirrhosis, with varying degrees of fibrosis.
Alcoholic Fatty Liver Disease
- Can be asymptomatic
- Right upper quadrant discomfort
- It can be asymptomatic
- Lack of appetite
- Weight loss, also as a result of a change in appetite
- Yellow color in skin and eyes, jaundice or icterus
- Fatigue or a general sense of weakness and lack of energy
- Nausea and vomiting
- Pain in the abdomen, accompanied by tenderness (especially pain in the upper right abdomen)
- Swollen abdomen due to an accumulation of excess fluid
- Mental confusion or problems with thinking clearly
In addition to the above features, some additional ones include:
- Edema (building up of fluid in the legs causing swelling)
- Redness in palms
- Easy bruising, abnormal bleeding at even the slightest of cuts
- In men, smaller testicles
Non-Alcoholic Fatty Liver Disease
In addition to all of the symptoms of alcoholic hepatitis, a few other features are unique to NAFLD:
- Red spider-like blood vessels throughout the skin
- Swelling of legs
Clinical manifestations and laboratory features are enough to identify alcoholic hepatitis in a patient with a long-term habit of heavy alcohol drinking. Heavy alcohol use is defined as drinking more than 100 g of alcohol per day for more than 20 years. It is the likely cause of acute hepatitis, provided other common causes of acute hepatitis are absent.
Thorough research must be done to understand the patient’s drinking habits – how often the patient drinks, whether they can function without it, and other such questions to gauge the body’s dependency on alcohol.
A patient with alcoholic hepatitis is typically 40 to 50 years of age, with a history of daily heavy alcohol drinking (more than 100 g per day for more than 20 years), which might occur in response to stressful situations.
Physical examination may reveal symptoms such as tender hepatomegaly, jaundice, and fever. In patients with advanced disease, signs of portal hypertension and ascites may be present; a bruit might be heard over the liver.
Ascites may result from either portal hypertension or obstruction of portal venous flow caused by swelling of hepatic cells.
The presence of stigmata of chronic liver disease, such as ascites, palmar erythema, spider angiomata, gynecomastia, and others, suggest underlying liver cirrhosis.
1. Liver tests abnormalities:
- Gamma-glutamyl transaminase (GGT):
- Lone elevation (with/without alanine transaminase [ALT] and aspartate aminotransferase [AST]) is a possible sign of occult alcohol abuse.
- AST: ALT ratio (liver transaminase):
- ALT is more specific for the liver than the AST because AST is also found in cardiac and skeletal muscle, the kidneys, and the lungs.
- Both AST and ALT are usually moderately elevated (< 500 IU/mL and < 400 IU/mL), with or without elevated GGT, in alcoholism.
- AST:ALT ratio ≥ 2 is associated with alcohol abuse (alcoholic hepatitis).
- Elevated serum bilirubin (> 5 mg/dL)
- Other liver marker abnormalities: Hypoalbuminemia, coagulopathy, and modest elevations of alkaline phosphatase
- Mean corpuscular volume (MCV):
Laboratory investigations to rule out other causes of acute hepatitis should be done, such as:
- Anti-hepatitis A IgM
- Hepatitis B surface antigen, anti-hepatitis B core IgM
- Anti-hepatitis C virus (HCV) antibodies, hepatitis C RNA
- Tests such as trans-abdominal U/S, MRI, and CT scans are carried out to obtain images of the liver, which provide valuable input in understanding the state of liver functioning.
- The imaging tests may reveal parallel tubular structures in the liver (venous collaterals). Portal vein flow reversal, ascites, and intra-abdominal venous collaterals on ultrasound indicate serious/irreversible liver injury.
Whether liver biopsy is necessary depends on the severity of the disease. A biopsy of the liver is useful in diagnosing the full extent of the liver damage, which helps in understanding the severity of both the fibrosis and the level of inflammation.
Furthermore, it helps in evaluating other possible liver diseases, such as fatty liver disease that may accompany alcoholic hepatitis. Liver biopsies are vital not only for alcoholic hepatitis; they are also used in non-alcoholic fatty liver disease to confirm the accumulation of fat in the liver.
Differential Diagnosis of Alcoholic Hepatitis
Alcoholic hepatitis should be differentiated from other causes of acute hepatitis. The striking features that identify alcoholic hepatitis are:
- Heavy alcohol drinking
- AST: ALT ratio ≥ 2, which is rarely observed in other causes of acute liver disease.
The differential diagnosis of acute hepatitis is wide and includes the following:
- Acetaminophen toxicity
- Drug-induced liver injury/idiosyncratic drug reactions (including herbal supplements and illicit drugs)
- Non-alcoholic steatohepatitis
- Acute viral hepatitis (hepatitis A, hepatitis B, hepatitis C, hepatitis D, hepatitis E, herpes simplex virus, Epstein-Barr virus, cytomegalovirus)
- Ischemic hepatitis
- Budd-Chiari syndrome
- HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome
- Acute fatty liver of pregnancy
- Wilson’s disease
- Autoimmune hepatitis
- Alpha-1 antitrypsin deficiency
- Toxin-induced hepatitis (e.g., mushroom poisoning, carbon tetrachloride)
High aminotransferases can also be noticed other diseases such as:
Treatment of Alcoholic Hepatitis
The management of alcoholic hepatitis includes several measures:
- Abstinence from alcohol
- Treatment of alcoholic withdrawal
- Hemodynamic and nutritional support
- Medical treatment
Patients at the initial stages of liver disease can still prevent further deterioration by abstaining from the cause of all the damage. This means abstinence from alcohol in the case of alcoholic hepatitis, and abstinence from obesity-causing products and behaviors in the case of NAFLD. Abstinence will also result in prevention of cirrhosis, in both cases.
Excessive alcohol drinking for a long time places the patient at risk of withdrawal symptoms, which also should be treated promptly.
Alcohol abstinence and general supportive measures are adequate in the treatment of mild to moderate alcoholic hepatitis. Medical treatment with glucocorticoids is not beneficial in the treatment of mild or moderate alcoholic hepatitis.
Hemodynamic and nutritional support
Patients with alcoholic hepatitis should be hydrated because poor oral intake associated with the disease may result in dehydration.
Overhydration should be avoided in patients with chronic liver disease and signs of cirrhosis because this may increase the volume of the ascites, increase the risk of hyponatremia, and predispose the patient to variceal hemorrhage.
Nutritional support with adequate calories, proteins, vitamins, and minerals is important to improve liver function.
Lifestyle changes, loss of body weight, and dietary modification in NAFLD patients can improve serum aminotransferase levels and reduce hepatic steatosis.
Medical treatment with glucocorticoids (prednisolone 40 mg/day for 28 days, followed by gradual tapering of the dose over 2 to 4 weeks) is indicated in patients with severe alcoholic hepatitis (MELD score > 20) in addition to the general supportive measures.
For non-alcoholic fatty liver disease, there are no specific medications, but anti-inflammatory medicines like aspirin, ibuprofen, naproxen sodium, or celecoxib, are often prescribed. The drugs currently being studied for the treatment of NAFLD include metformin, pioglitazone, vitamin E, and omega-3 fatty acids. The approach to NAFLD management focuses on the improvement of risk factors for NASH (i.e., obesity, insulin resistance, metabolic syndrome, and dyslipidemia).
When the disease becomes chronic, there is a greater risk of complete liver failure. In such cases, the only treatment offered is a liver transplant. However, surgery, too, is complicated, as the mortality rate in alcoholic patients is high. Nevertheless, surgery is the last resort for end-stage disease despite prevailing complications.
Counseling and therapy
Referral of patients to alcohol counselors/alcohol treatment programs is a routine process in the management of patients with alcoholic liver disease. Therapy helps many patients break the habit of drinking or fight obesity. Counseling helps patients fight the disease before it gets any worse and also helps keep the patients and their symptoms under observation. There are also many support groups, the most famous being Alcoholics Anonymous, which helps patients abstain from alcohol.
Not many counseling methods have been established to help patients deal with NAFLD. Anti-fibrotic therapy for non-alcoholic fatty liver disease is still in its initial stages of development.
The presence of ascites, variceal hemorrhage, deep encephalopathy, or hepatorenal syndrome predicts a poor prognosis. Patients with severe alcoholic hepatitis who are critically ill have 30-day mortality rates > 50%. Model for End-Stage Liver Disease (MELD) score ≥ 21 is associated with high mortality in alcoholic hepatitis.